stonedinvestor said: Do you mean MARA? Yeah, I forgot MARA is in to mind altering meds now, crypto mining was a side hustle. These work well!
--Carrier Global plans to repurchase $1B of shares in second half » 06:55 CARR -- Goldman Sachs initiated coverage of LandBridge(LB)with a Buy rating and $35 price target. The firm is constructive on the outlook for the company, saying its New Mexico-Texas Stateline acreage is well positioned to capture continued Permian Basin growth, notably for produced water disposal. Wells Fargo and Raymond James also started coverage of the name with Buy-equivalent ratings. Meanwhile, Barclays, Piper Sandler, and Citi initiated the stock with Neutral-equivalent ratings. Morgan Stanley initiated coverage of Alumis(ALMS)with an Overweight rating and $36 price target. The firm says that while key de-risking catalysts for ESK-001 are in 2026, the stock's current valuation offers an attractive entry point relative to peers. Leerink, Cantor Fitzgerald, and Guggenheimer also started coverage of the name with Buy-equivalent ratings.
TD Cowen went turtle on us and lowered Sketcher's PT by a whopping $3 Just keep the fuck quiet! Worthless..... we are going with this sentiment Morgan Stanley upgradedSkechers(SKX)to Overweight from Equal Weight with a price target of $80, up from $60, as part of a broader research note on Branded Apparel and Footwear. The company "scored impressively high" on the firm's global brand momentum and perception survey scorecards, while the recent North America / E.U. sports- wear channel checks for Skechers was also "upbeat," leaving the firm "incrementally positive on the brand."
Ayyyyyyyyyyyyyyyyyy. Someday children... Papa will tell you the story about when he owned CRS at $57.... Thought myself smart... I have to check if I was lucky I got $90 but I may of sold in the high $70's. Super well run company. CRS Carpenter Technology Corporation $121.50-3.38(-2.71%)4:00 PM 07/24/24 NYSE |$USD |Pre-Market:$125.00+3.50(+2.88%)8:00 AM
I see why your friend did that. It was an apparently level area but time is always needed./ I just took a peek at the chart. Worst case $80 most likely case $98. I would be a buyer at that level---But I give her a shot at stopping right here as well the recent uptrend started at April 19 $106<--- If the market wasn't sour this really would not be a bad spot////
It was weird I saw the options were indicating a big move and these bios can't be about $'s at this stage so what are they going to do have earn and say our drug is falling behind?.. Now that i think about this was a no brainer yesterday.. As far as I can tel this all just because they are furthering the process/// VKTX Viking Therapeutics, Inc. $50.41-1.13(-2.19%)4:00 PM 07/24/24 NASDAQ |$USD |Pre-Market:$58.00+7.59(+15.06%)8:19 AM Viking sends Lilly, Novo lower as obesity drug enters late-stage program NewsToday, 7:01 AM